Clinical Trial Update: Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG [Phase 3]

View source ↗

Summary

This completed Phase III randomized trial in patients with limited-stage small cell lung cancer evaluated survival after vaccination with adjuvant BEC2 and Baci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)
• BEC2

Snippet

Sponsor: Eli Lilly and Company | Conditions: Carcinoma, Small Cell Lung | Phase 3 | Status: COMPLETED